The novel pan-PIM kinase inhibitor, PIM447, displays dual antimyeloma and bone-protective effects, and potently synergizes with current standards of care

  1. Paíno, T.
  2. Garcia-Gomez, A.
  3. González-Méndez, L.
  4. San-Segundo, L.
  5. Hernández-García, S.
  6. López-Iglesias, A.-A.
  7. Algarín, E.M.
  8. Martín-Sánchez, M.
  9. Corbacho, D.
  10. Ortiz-De-Solorzano, C.
  11. Corchete, L.A.
  12. Gutiérrez, N.C.
  13. Maetos, M.-V.
  14. Garayoa, M.
  15. Ocio, E.M.
Revue:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Année de publication: 2017

Volumen: 23

Número: 1

Pages: 225-238

Type: Article

DOI: 10.1158/1078-0432.CCR-16-0230 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus